Hyperfine, Inc. (HYPR)
1.01
+0.02
(+1.88%)
USD |
NASDAQ |
Jan 09, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
Hyperfine EPS Diluted (Quarterly): -0.1394 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | -0.2877 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.02M |
| Revenue (Quarterly) | 3.437M |
| Total Expenses (Quarterly) | 14.46M |
| Enterprise Value | 76.29M |
| Gross Profit Margin (Quarterly) | 53.77% |
| Profit Margin (Quarterly) | -320.6% |
| Earnings Yield | -51.89% |
| Normalized Earnings Yield | -51.03 |